Our Services
Medical Information
Helpful Resources
Published on: 9/24/2026
Doctors generally recommend lipid-lowering medication when LDL cholesterol or triglycerides stay elevated after about three to six months of diet, exercise, and weight changes, or immediately when cardiovascular risk is already high. Statins are usually the first choice, and treatment is typically advised for people with existing atherosclerotic cardiovascular disease, LDL of 190 mg/dL or higher, diabetes between ages 40 and 75, or an elevated 10-year risk score. Other triggers include very high triglycerides, a strong family history of early heart disease, or inherited conditions such as familial hypercholesterolemia. Thresholds shift based on your age, blood pressure, smoking status, kidney and thyroid function, and how well you tolerate medication, so there are several important factors to weigh before starting or delaying treatment; see below for the complete details.
If you are unsure whether your numbers, symptoms, or risk factors warrant medication, guessing can mean years of untreated risk or unnecessary prescriptions, and a short assessment can help you frame the right questions for your doctor. Take a free, instant, online symptom check to better understand what may be driving your results and what steps to take next.
Last reviewed for medical accuracy: 09/24/2026
Dyslipidemia—an imbalance of cholesterol or fats (lipids) in the blood—is a key risk factor for heart disease and stroke. Many people can manage mild dyslipidemia through diet, exercise and lifestyle changes. But sometimes, cholesterol-lowering medications are recommended to prevent serious complications. Below, you’ll find an overview of when doctors typically prescribe medication for dyslipidemia, based on current guidelines and credible sources.
Dyslipidemia refers to abnormal levels of:
Left untreated, these imbalances can lead to fatty build-up in arteries (atherosclerosis), increasing the risk of heart attack, stroke and other vascular problems.
Before starting medication, most doctors emphasize:
These steps can lower LDL-C by up to 20–30% and raise HDL-C by 5–10%. If levels remain high despite 3–6 months of consistent effort, medication may be needed.
Common statins include:
Possible side effects: muscle aches, elevated liver enzymes. Serious reactions are rare.
Once medication starts, doctors will:
If you’re concerned about symptoms such as unexplained chest pain, leg pain when walking, or unusual fatigue, it’s important to assess them promptly. You might consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.
Medication decisions should always be made in partnership with your healthcare provider. Reach out if you:
Never ignore serious or life-threatening symptoms. If you suspect an emergency (e.g., crushing chest pain, sudden weakness or speech difficulty), seek immediate medical attention.
Managing dyslipidemia reduces your risk of heart attack, stroke and other complications. Talk to your doctor about your individual risk profile and whether medication is right for you. If you ever have symptoms that could signal a serious condition, don’t hesitate—always speak to a doctor.
(References)
* Márk L. [Hyperlipidemia]. Orv Hetil. 2006 Jul 9;147(27):1284-5. PMID: 16927886.
* Moulin P. CEPHEUS Trial. Arch Cardiovasc Dis. 2008 Sep;101(9):513-4. doi: 10.1016/j.acvd.2008.09.002. Epub 2008 Nov 6. PMID: 19041834.
* Dixon DB, Kornblum AP, Steffen LM, Zhou X, Steinberger J. Implementation of lipid screening guidelines in children by primary pediatric providers. J Pediatr. 2014 Mar;164(3):572-6. doi: 10.1016/j.jpeds.2013.10.027. Epub 2013 Nov 16. PMID: 24252785.
* Karr S. Epidemiology and management of hyperlipidemia. Am J Manag Care. 2017 Jun;23(9 Suppl):S139-S148. PMID: 28978219.
* Ferro CJ, Mark PB, Kanbay M, Sarafidis P, Heine GH, Rossignol P, Massy ZA, Mallamaci F, Valdivielso JM, Malyszko J, Verhaar MC, Ekart R, Vanholder R, London G, Ortiz A, Zoccali C. Lipid management in patients with chronic kidney disease. Nat Rev Nephrol. 2018 Dec;14(12):727-749. doi: 10.1038/s41581-018-0072-9. PMID: 30361677.
* Newman CB, Blaha MJ, Boord JB, Cariou B, Chait A, Fein HG, Ginsberg HN, Goldberg IJ, Murad MH, Subramanian S, Tannock LR. Lipid Management in Patients with Endocrine Disorders: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2020 Dec 1;105(12). doi: 10.1210/clinem/dgaa674. PMID: 32951056.
* Kobo O, Michos ED, Roguin A, Bagur R, Gulati M, Mamas MA. Recommended and observed statin use among US adults with and without cancer. Eur J Prev Cardiol. 2024 Aug 9;31(10):1251-1257. doi: 10.1093/eurjpc/zwae057. PMID: 38332751.
* Hohneck A, Weingärtner O. [ESC guidelines on dyslipidemia update 2025 : New recommendations for the practice]. Herz. 2026 Feb;51(1):4-11. doi: 10.1007/s00059-025-05354-6. Epub 2025 Dec 9. PMID: 41366604.
* Siegel PM, Katzmann JL, Weinmann-Menke J, Landmesser U, Schunkert H, Baldus S, Böhm M, Laufs U, Lüscher TF, Hilgendorf I. A practical guide to the management of dyslipidaemia. Clin Res Cardiol. 2026 Feb;115(2):185-197. doi: 10.1007/s00392-025-02833-y. Epub 2026 Jan 8. PMID: 41504909; PMCID: PMC12823703.
* Anderson TS, Wilson LM, Sussman JB. Implications of the 2026 Dyslipidemia Guideline for Primary Prevention Statin Therapy. JAMA. 2026 Aug 18;336(7):557-564. doi: 10.1001/jama.2026.11246. PMID: 42475062; PMCID: PMC13386295.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.